Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, January 27, 2015
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

First Major Analysis Of Human Protein Atlas Published
Friday, January 23, 2015
A research article published in Science presents the first major analysis based on the Human Protein Atlas, including a detailed picture of the proteins that are linked to cancer, the number of proteins present in the bloodstream, and the targets for all approved drugs on the market.

DNASTAR Appoints Tom Lynch Vice President of Sales
Wednesday, January 21, 2015
Dr. Lynch played key roles in the successful launch of Aldevron’s recombinant protein business.

Denator Expands Asian Distributor Network
Wednesday, January 21, 2015
Company appoints ASPEC Technologies and D.I Biotech as new distributors of its Stabilizor™ system.

Abcam Acquires Firefly BioWorks
Wednesday, January 21, 2015
Acquisition will expand Abcam’s capabilities in multiplex analysis.

Awards for Bio-Rad's Protein Expression Products and Genomic Workflow Solutions
Monday, January 19, 2015
BioInformatics LLC has recognized Bio-Rad with two prestigious Life Science Industry Awards for “Best Protein Expression & Analysis Products” and “Best Workflow Solutions — Genomics.”

Novel Approach to Visualize & Measure Protein Complexes in Tumors
Monday, January 19, 2015
Moffitt Cancer Center researchers have developed a PLA to analyze biological processes occurring within tumors.

CiToxLAB Announces the Appointment of Dr. Philippe Ancian as Senior Director
Wednesday, January 14, 2015
This appointment will allow to drive current and future developments at CiToxLAB’s European and North American sites in the area of preclinical and clinical biomarkers, which is currently experiencing strong growth.

MDxHealth CEO to Keynote at Biomarkers from Research to Clinic Conference
Monday, January 05, 2015
MDxHealth CEO Dr Jan Groen to deliver Keynote presentation at Biomarkers from Research to Clinic conference.

Oncodesign Enters into a Services Agreement with Eisai
Friday, December 26, 2014
The program aims to identify useful patient stratification biomarkers for Eisai’s Halaven® eribulin using patient-derived xenograft models.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2718
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn